Adjunct Professor at the University of Nebraska Medical Center
As of 2025 · Last known relationship
Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part I-Coordinated Registry Networks and Systemic Coordinated Inter-Organizational Networks
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part II-How Coordinated Registry Networks Operate Like Systemic Coordinated Inter-Organizational Networks
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part III-Questions for Translational Science and Action Theory
Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways "LEAN" working group
Designed, led, and conducted numerous clinical trials, including EPIC, PROLOG, EPILOG, EPISTENT, IMPACT, IMPACT II, TOTAL, PRIDE, ESPRIT, MEND-1, ELECT, and SUPPORT
Evaluating the potential of fast healthcare interoperability resources for clinical registry data submission
Framework for Improving Patient Safety: Reference Model for FHIR-Enabled, Patient-Centric Home Medication List Management and Medication Reconciliation
James Enlou Tcheng is a Duke University faculty leader whose work connects interventional cardiology, cardiovascular trials, clinical informatics, and academic appointments. He is Professor of Medicine, Associate Dean for Academic Appointments, and Professor of Family Medicine and Community Health at Duke. His interests include antithrombotic therapies, artificial intelligence, clinical data standards, interoperability, and structured reporting. He has designed, led, and conducted numerous clinical trials, including EPIC, EPILOG, EPISTENT, and SUPPORT. His recent publications address FHIR-enabled registry submission, machine-learning fairness, patient-centered medication reconciliation, antithrombotic regimens, and pulse-oximetry equity. Tcheng earned his M.D. from Johns Hopkins University in 1982, completed internal medicine training at Barnes-Jewish Hospital, and was a Duke cardiology fellow from 1986 to 1988. He was an Adjunct Professor at the University of Nebraska Medical Center from 2022 to 2025.
Machine learning performance for a small dataset: random oversampling improves data imbalances and fairness
The high price of equity in pulse oximetry: A cost evaluation and need for interim solutions
Translating proof-of-concept for platelet slip into improved antithrombotic therapeutic regimens
Each topic is linked to its supporting source in Sources.
Training includes Adjunct Professor at the University of Nebraska Medical Center, Informed a large audience about optimizing strategies for CDS adoption and use at the AMIA 2017 Annual Symposium, Chair of the Informatics and Health IT Committee of the American College of Cardiology, and Cardiology fellow at Duke University School of Medicine, plus 22 more records.
Explore education and trainingAs of 2025
As of 2017
As of 1996
As of 1988
As of 1985
As of 1983
As of 1982
Antithrombotic therapies in cardiovascular disease, clinical informatics, artificial intelligence, and information technology systems[7]
Clinical informatics, including clinical data standards, interoperability solutions, and structured reporting in clinical workflows[7]